Cytogenetic studies have shown frequent clonal abnormalities in papillary carcinoma (PFC) 
genetic analyses of these tumors have been reported (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . A preliminary study of 12 thyroid carcinomas from our group (6) demonstrated abnormalities ofchromosomes 3 and 10 in FTC and PTC, respectively. Others have observed anomalies of chromosome 7, 10, or 11 in PTC (3-5, 7, 9 ). An oncogene associated with PTC, formed by rearrangement ofthe ret oncogene (mapped to 10qI 1.2) and H4, another chromosome 10 gene of unknown function (mapped to 10q21.2), has been described on chromosome 10 at ql I-q12 (16) (17) (18) . Although loss of heterozygosity (LOH) of specific chromosome loci may suggest the presence of tumor suppressor genes important for the development or progression of particular tumors (19) , we are not aware that such studies have been performed on nonmedullary thyroid neoplasms. The present cytogenetic and LOH studies were performed to determine if consistent cytogenetic abnormalities are associated with various grades and morphologic types of differentiated thyroid cancer, to determine likely chromosomal regions for molecular genetic investigations, and to determine if there is evidence of allelic loss in thyroid neoplasia.
Methods
Cytogenetic analysis. Chromosome studies were performed on fresh surgical specimens from 31 patients who were seen at the Mayo Clinic between August 1989 and May 1990 . Details of our methods for solid tumor culture and cytogenetic analysis have been described previously (20) . Briefly, small pieces of tissue from each specimen were minced and treated with an enzyme solution, washed, and suspended in 50:50 MEM alpha:Chang's media with 20% fetal bovine serum. Cells were cultured on 16 chamber slides, then harvested in situ on days 2-26, when there was sufficient mitotic activity for chromosome analysis. In most cases 30 metaphases from each tumor were analyzed using quinacrine mustard for fluorescent Q-bands. Most specimens were also stained with Leishman's stain after trypsinization for G-bands (GTLbanding), and Distamycin A/DAPI as needed. The karyotype of each cell was described according to the International System for Human Cytogenetic Nomenclature (21) .
We strictly defined clonality. An abnormal clone consisted of two or more metaphases with the same additional chromosome or structural abnormality, or three or more metaphases lacking the same chromosome. In addition, the abnormalities must have occurred in two or more independent cultures. Using this definition we separated ourcytogenetic results into four categories: a normal specimen contained no apparent chromosome abnormality; a nonclonal specimen contained no consistent abnormality; a simple clonal specimen contained metaphases with two or less consistent chromosome abnormalities; and a complex clonal specimen contained metaphases with three or more consistent chromosome abnormalities.
Loss of heterozygosity studies. Fig. 2 .
One low grade FTC (patient 43) had loss of the Y chromosome as the sole clonal abnormality. Two grade 2 FTC (patients 46 and 47), one locally recurrent and one primary, were hypodiploid and had similar complex karyotypes. The modal chromosome numbers of these two cases were near haploid and both had relative gains of chromosomes 5, 7, 12, 19, and 20. Neither of these tumors had clonal structural abnormalities. Representative karyotypes of these tumors are shown in Figs. 3 and 4. Each cytogenetically abnormal FTC was an oxyphil cell variant (1) .
Loss ofheterozygosity studies. Our LOH study group consisted of 12 PTC, 6 FTC, and 3 FA (Table II) . Representative autoradiography results of eight follicular tumors after restriction enzyme digestion with Hind III and hybridization with radiolabeled probe pH3H2 are illustrated in Fig. 5 . LOH ofall informative loci on chromosome 3p was observed in all six FTC but not in the three FA (Fig. 6) . Loss of heterozygous alleles on chromosomes 16p and 17p was observed in one FTC (patient 46). LOH of chromosome 10 loci was observed in Genetics ofThyroid Cancer Cytogenetic studies of at least 152 nonmedullary thyroid neoplasms have been reported (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Approximately 50% of the 61 nonmedullary thyroid carcinomas had an abnormal karyotype, while in our present study of 31 thyroid cancers 9 (28%) had clonal abnormalities. Loss of heterozygosity studies have not been previously reported for nonmedullary thyroid tumors.
As in our initial study (6) we observed that tumors ofhigher histologic grade were more often cytogenetically abnormal. 4 of 7 grade 2 tumors had clonal abnormalities, while only 4 of 23 grade 1 tumors were abnormal. Moreover, the grade 3 PTC had a complex abnormal karyotype. Most of the cytogenetically abnormal tumors were higher grade primary tumors (grade 2), or from local recurrences (grade 3 and grade 2). Four cytogenetically abnormal grade 1 tumors were from regional lymph node metastases. Tumor grade has previously been reported at Mayo to be prognostically important in both PTC and FTC (51) . Cytogenetic reports of thyroid cancers from other groups, however, have not considered the tumor grade.
We also determined that there were specific chromosomal abnormalities associated with the morphologic subtypes of PTC and FTC. Previously we had reported that FTC showed complex clonal karyotypes, with structural abnormalities of 3p (6). We did not observe structural 3p anomalies in the five FTC we analyzed in our current series; however, two tumors were hypodiploid with consistent loss of chromosome 3. Including this report, cytogenetic studies of 17 Additional LOH studies of FTC using more probes specific for shorter segments on chromosome 3p may help to elucidate which region may be specific for these malignant thyroid tumors. Cytogenetic abnormalities ofthe short arm ofchromosome 3 have also been frequently observed in ovarian adenocarcinoma, small cell lung carcinoma (SCC), renal cell carcinoma (RCC), bladder cancer, gastric cancer, mesothelioma, and pleomorphic adenoma of the salivary gland (52) . In contrast to LOH studies of medullary thyroid carcinoma that have not shown loss on chromosome 3p (53) , such studies performed on other tumor types such as RCC and SCC have shown loss of alleles on chromosome 3p (54, 55) . The critical region in RCC appears tobe 3pI3-p14.2, while the region of3pl4-p23 appears to be important in SCC (54, 55) . This region of 3p(p21-p14) has recently been reported to contain a ras-related gene, ARH12 (56) .
From a review of the literature and the results presented here, candidate chromosome abnormalities that may be implicated in the pathogenesis of PTC include trisomy 5, loss of Y, deletion 1 1q23, structural or numerical abnormalities ofchromosome 7, or structural abnormalities of chromosome 10. Two of our cases had trisomy 5, one as the sole clonal abnormality. Trisomy S is infrequent in other solid tumors (57), has not been reported in PTC, but has been observed in FA in addition to other chromosome gains (8, 12) . Loss of the Y chromosome has been observed in the bone marrow ofnormal elderly males (58), nonneoplastic brain tissue (59) , and in many kinds of tumors (57) , and is therefore not specific for thyroid or other neoplasms. Olah et al. (7) observed abnormalities at 1 1q23 in three cases of PTC and suggested that deletion of 1 lq may be specific for PTC. However, this abnormality has not been reported by others in PTC. Structural or numerical abnormalities of chromosome 7 have now been observed in five cases of PTC from four groups (4, 5, 1 1; current report), and in four cases they represented the sole clonal abnormality. Alterations ofchromosome 7 other tumor types such as melanoma (60, 61) , bladder carcinoma (62, 63) , and mesothelioma (64) noma, which implies a more advanced tumor with a less favorable prognosis (45) . Abnormalities of chromosome 10 in the region ofq 1 -q26 have now been described in 11 PTC (3-6, 1 1; Pierotti, M. A., et al., submitted for publication; and current report) and in 9 of these cases structural 1 Oq abnormalities were the sole clonal 4 In summary, the results of this genetic study of thyroid carcinomas support the hypothesis that FTC and PTC have different genetic mechanisms underlying their pathogenesis. We favor the model of thyroid tumor formation and progression proposed by Lemoine et al. (48) , and would further propose that alterations on chromosome 3p may facilitate the progression of FA to FTC, while inv(l0), with rearrangement of the ret oncogene, is specifically involved in the pathogenesis of PTC (Fig. 7) . Other, as yet unknown, genetic events may contribute to the rare transformation to an undifferentiated (anaplastic) carcinoma (1, 51) .
While the overall prognosis of PTC and FTC is good, thus making clinical correlation of these cytogenetic and molecular genetic findings premature, perhaps the risk for metastases or recurrence may eventually be predicted from the presence or absence ofgenetic abnormalities. For the present, however, we believe that the results of these studies have provided a substrate for further more sophisticated genetic investigation of these relatively common thyroid tumors.
